Chongqing Pharscin Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003308
  • SHE: 002907
CNY
15.10
-0.15 (-0.98%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
197.09
209.91
196.64
182.32
198.54
236.39
156.32
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
197.09
209.91
196.64
182.32
198.54
236.39
156.32
Raw Material Cost
93.64
94.92
100.29
88.50
93.13
105.69
78.67
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.29
0.07
0.00
0.00
0.05
0.00
0.00
Selling and Distribution Expenses
67.23
69.41
76.57
62.34
77.15
77.80
63.32
Other Expenses
0.91
1.51
2.80
1.97
2.22
0.98
1.83
Total Expenditure (Excl Depreciation)
170.27
179.48
204.89
170.55
192.55
193.33
160.25
Operating Profit (PBDIT) excl Other Income
26.8
30.4
-8.2
11.799999999999999
6
43.099999999999994
-3.9000000000000004
Other Income
3.55
6.67
-0.85
15.42
5.38
7.23
5.71
Operating Profit (PBDIT)
55.16
62.48
12.84
50.03
32.65
71.65
22.77
Interest
0.29
0.07
0.00
0.00
0.05
0.00
0.00
Exceptional Items
0.70
0.57
0.26
0.41
0.28
0.47
7.08
Gross Profit (PBDT)
103.45
114.99
96.35
93.81
105.40
130.70
77.65
Depreciation
25.38
25.38
23.01
23.01
21.44
21.44
21.78
Profit Before Tax
30.20
37.60
-9.92
27.42
11.45
50.68
8.07
Tax
3.15
8.69
0.62
11.79
0.89
8.95
2.62
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
30.19
32.79
-7.37
18.51
13.60
40.36
2.15
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
30.19
32.79
-7.37
18.51
13.60
40.36
2.15
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-3.15
-3.88
-5.34
-2.87
-1.66
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
27.05
28.91
-12.71
15.63
11.93
40.36
2.15
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,737.78
1,724.38
1,691.32
1,688.75
1,684.76
1,700.50
1,660.00
Earnings per share (EPS)
0.07
0.08
-0.02
0.04
0.03
0.1
0.01
Diluted Earnings per share
0.07
0.08
-0.02
0.04
0.03
0.1
0.01
Operating Profit Margin (Excl OI)
13.31%
14.5%
-4.75%
6.36%
2.94%
18.18%
-3.02%
Gross Profit Margin
28.2%
30.0%
6.66%
27.67%
16.57%
30.51%
19.1%
PAT Margin
15.32%
15.62%
-3.75%
10.15%
6.85%
17.07%
1.38%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is -6.10% vs 6.77% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is -6.57% vs 327.56% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is -7.53% vs 307.30% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 200.00% vs 0.00% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

Compare Quarterly Results Of Chongqing Pharscin Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
197.09
0
197.09
Other Operating Income
0.00
0.00
0.00
Total Operating income
197.09
0
197.09
Raw Material Cost
93.64
0
93.64
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.29
0
0.29
Selling and Distribution Expenses
67.23
0
67.23
Other Expenses
0.91
0.00
0.91
Total Expenditure (Excl Depreciation)
170.27
0
170.27
Operating Profit (PBDIT) excl Other Income
26.82
0.00
26.82
Other Income
3.55
0
3.55
Operating Profit (PBDIT)
55.16
0
55.16
Interest
0.29
0
0.29
Exceptional Items
0.70
0
0.70
Gross Profit (PBDT)
103.45
0
103.45
Depreciation
25.38
0
25.38
Profit Before Tax
30.20
0
30.20
Tax
3.15
0
3.15
Provisions and contingencies
0
0
0.00
Profit After Tax
30.19
0
30.19
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
30.19
0
30.19
Share in Profit of Associates
0
0
0.00
Minority Interest
-3.15
0
-3.15
Other related items
0.00
0.00
0.00
Consolidated Net Profit
27.05
0
27.05
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,737.78
0
1,737.78
Earnings per share (EPS)
0.07
0
0.07
Diluted Earnings per share
0.07
0
0.07
Operating Profit Margin (Excl OI)
13.31%
0%
0.00
13.31%
Gross Profit Margin
28.20%
0%
0.00
28.20%
PAT Margin
15.32%
0%
0.00
15.32%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 19.71 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -6.10% vs 6.77% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -0.71% vs 7.01% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.70 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -6.57% vs 327.56% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 126.89% vs 72.46% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.16 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -7.53% vs 307.30% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 89.01% vs 0.74% in Jun 2025

Quarterly - Interest
Interest 0.03 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 200.00% vs 0.00% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.31%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025